Search results
GlycoMimetics reports Phase 3 trial of uproleselan falls short By Investing.com
Investing.com· 9 hours ago(NASDAQ:GLYC), a biotechnology firm engaged in the development of therapies for cancer and...
Middle East Marine Put on Blast for 'Worst Case of Serial Seafarer Abandonment Ever Seen'
MarineLink· 10 hours ago...International Transport Workers’ Federation (ITF) is calling out Dubai-based ship management ...
Pfizer and Genmab’s Tivdak wins full FDA approval for cervical cancer
Pharmaceutical Technology via Yahoo Finance· 7 days agoGlobalData is the parent company of Pharmaceutical Technology. Pfizer is also seeking European...
Loving Outdoors Living With Reiff Knives' New Take On The Classic Leuku Survival Knife
International Business Times· 4 days agoThis primordial way of living, where man and nature intertwine, is what inspired two brothers,...
Merck's KEYTRUDA shows survival benefit in gastric cancer trial By Investing.com
Investing.com· 5 days agoMerck & Co., Inc., a leading pharmaceutical company, announced positive results from the Phase 3...
The Best Canned Beef Stew Is Not From A Powerhouse Brand
Mashed via Yahoo News· 7 days agoYes, as in the survival food kit and camping supply brand. The stew does have a 4.7-star rating on...
Farm package designed to boost Georgia’s top industry of agriculture signed into law
Columbus Ledger-Enquirer· 6 days agoGov. Brian Kemp signed a package of bills Tuesday aimed at improving agriculture, by far Georgia’s No.-1 industry. Kemp touted the economic development successes his administration has brought ...
Obituary for Tay Roy "TR" David Kibble - East Idaho News
EastIdahoNews.com· 4 days agoOn March 5, Tay Roy “TR” David Kibble passed away from a heart attack at his Idaho Falls home. Tay...
Sentynl Therapeutics Announces Global Acquisition of Zokinvy® (Lonafarnib) for Treatment of...
Tehachapi News· 3 days agoSentynl, a Zydus Group company, receives worldwide proprietary rights to Zokinvy, adding to portfolio of biopharmaceuticals for rare and ultra-rare diseases
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 5 days agoPfizer also recently said its new drug, Adcetris, improved overall survival, progression-free ...